Skip to main
NTRA

Natera (NTRA) Stock Forecast & Price Target

Natera (NTRA) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 29%
Buy 59%
Hold 12%
Sell 0%
Strong Sell 0%

Bulls say

Natera is well positioned in the growing MRD market with a dominant market share and successful product offering, Signatera, which has experienced significant growth. With a diverse portfolio expanding into new markets, strong financials and a positive outlook for future growth, it is no surprise that the company has received an Outperform rating and a $275 price target. However, potential risks and challenges, such as competition and reliance on senior management, should be carefully monitored.

Bears say

Natera is a leader in diagnostic and research services, but faces challenges in maintaining its momentum and profit margins due to potential limitations on its unique technologies, inconsistent realization of planned catalysts and increasingly competitive and intense markets they operate in, also posing moderate risks to profitable operation.

Natera (NTRA) has been analyzed by 17 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 59% recommend Buy, 12% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Natera and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Natera (NTRA) Forecast

Analysts have given Natera (NTRA) a Buy based on their latest research and market trends.

According to 17 analysts, Natera (NTRA) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $263.94, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $263.94, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Natera (NTRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.